Christine Ocampo, Vice President, Finance at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 65,000 shares at $3.49 ($227K) on 2012-09-17, disclosed to the SEC on 2012-09-19.
Scheduled sale ($227k) by Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-10-24 | $25K | — | Filing → |
| AVNR | SELL | 2014-09-17 | $520K | — | Filing → |
| AVNR | SELL | 2014-08-28 | $13K | — | Filing → |